Lindsay Angus

11PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

|Nov 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer.

Sophie L Gerritse, Erik J van Helden, Anne I J Arens

|Sep 09, 2023
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling.

Lindsay Angus, Marcel Smid, Saskia M Wilting

|Nov 17, 2022
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.

Sarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias

|May 27, 2021
Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.

Pauline A J Mendelaar, Marcel Smid, Job van Riet

|Apr 30, 2021
The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.

Lindsay Angus, Martijn P A Starmans, Ana Rajicic

Pageof 2

Frequent Collaborators

6 joint publications

John W M Martens

4 joint publications

Martijn P Lolkema

4 joint publications

Saskia M Wilting

3 joint publications

C Willemien Menke-van der Houven van Oordt